1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Psychosis Global Clinical Trials Review, H2, 2014

Psychosis Global Clinical Trials Review, H2, 2014

  • July 2014
  • -
  • Global Data
  • -
  • 92 pages

Psychosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Psychosis Global Clinical Trials Review, H2, 2014" provides data on the Psychosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Psychosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Psychosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Psychosis Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Psychosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Psychosis to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Psychosis to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Psychosis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Psychosis Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Johnson and Johnson 33
Clinical Trial Overview of Johnson and Johnson 33
AstraZeneca PLC 35
Clinical Trial Overview of AstraZeneca PLC 35
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Otsuka Holdings Co., Ltd. 39
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 39
ZonMw 40
Clinical Trial Overview of ZonMw 40
North Shore-Long Island Jewish Health System, Inc. 41
Clinical Trial Overview of North Shore-Long Island Jewish Health System, Inc. 41
Acadia Pharmaceuticals Inc. 42
Clinical Trial Overview of Acadia Pharmaceuticals Inc. 42
Clinical Trial Overview of Top Institutes / Government 43
Department of Health, South Africa 43
Clinical Trial Overview of Department of Health, South Africa 43
Yale University 44
Clinical Trial Overview of Yale University 44
U.S. Department of Veterans Affairs 45
Clinical Trial Overview of U.S. Department of Veterans Affairs 45
The University of Hong Kong 46
Clinical Trial Overview of The University of Hong Kong 46
Maastricht University 47
Clinical Trial Overview of Maastricht University 47
Centre for Addiction and Mental Health 48
Clinical Trial Overview of Centre for Addiction and Mental Health 48
University of British Columbia 49
Clinical Trial Overview of University of British Columbia 49
Melbourne Health 50
Clinical Trial Overview of Melbourne Health 50
University of Cologne 51
Clinical Trial Overview of University of Cologne 51
New York State Psychiatric Institute 52
Clinical Trial Overview of New York State Psychiatric Institute 52
Five Key Clinical Profiles 53
Appendix 90
Abbreviations 90
Definitions 90
Research Methodology 91
Secondary Research 91
About GlobalData 92
Contact Us 92
Disclaimer 92
Source 92

List of Tables
Psychosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Psychosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Psychosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Psychosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Psychosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Psychosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Psychosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Psychosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Psychosis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Psychosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Psychosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Psychosis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Psychosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Psychosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Psychosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Psychosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Psychosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Psychosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Psychosis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Psychosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Psychosis Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Psychosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Psychosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Psychosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Psychosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Psychosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 33
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 35
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 37
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 38
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 39
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by ZonMw, 2014* 40
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by North Shore-Long Island Jewish Health System, Inc., 2014* 41
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Acadia Pharmaceuticals Inc., 2014* 42
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014* 43
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 44
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 45
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014* 46
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University, 2014* 47
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for Addiction and Mental Health, 2014* 48
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 49
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Melbourne Health, 2014* 50
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2014* 51
Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2014* 52

List of Figures
Psychosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Psychosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Psychosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Psychosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Psychosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Psychosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Psychosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Proportion of Psychosis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Psychosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Psychosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Psychosis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Psychosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Psychosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Psychosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Psychosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Psychosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Psychosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Psychosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Psychosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Psychosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Psychosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Psychosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 91

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.